Document Classification

Section Type: RESULTS

Text: Study 1 (non-diabetic subjects) S (I) 2. 81 vs. 2. 63 x 10 (-4) min (-1) per microU/ml (p = 0. 54), S (G) 0. 020 vs. 0. 020 min (-1) (p = 0. 90), AIR (0-10) min 3305 vs. 3450 microU/min/ml (p = 0. 71) ; Study 2 (patients with type 2 diabetes) S (I) 0. 59 vs. 0. 85 x 10 (-4) min (-1) per microU/ml (p = 0. 15), S (G) 0. 013 vs. 0. 014 min (-1) (p = 0. 71), AIR (0-10) min 65 vs. 119 microU/min/ml (p = 0. 14), placebo vs. valsartan, respectively.